news
Vaccine triggers HIV antibodies in monkeys
Scientists at the Scripps Research Institute developed a new HIV vaccine method that successfully prompted broadly neutralizing antibodies (bnAbs) in primates. This is a significant step toward developing effective HIV vaccines for humans. The research was published in Nature.
Scientists at the Scripps Research Institute developed a new HIV vaccine method that successfully prompted broadly neutralizing antibodies (bnAbs) in primates. This is a significant step toward developing effective HIV vaccines for humans. The research was published in Nature.
The architecture take
Getting the immune system to produce these specific antibodies has been the holy grail for an HIV vaccine for decades. This animal study moves us closer to a human trial, shifting the immune response in a new way.